Imagin Medical Stock Fundamentals
| IMEXF Stock | USD 0.0001 0.00 0.00% |
Imagin Medical fundamentals help investors to digest information that contributes to Imagin Medical's financial success or failures. It also enables traders to predict the movement of Imagin Pink Sheet. The fundamental analysis module provides a way to measure Imagin Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Imagin Medical pink sheet.
Imagin |
Imagin Medical Company Shares Outstanding Analysis
Imagin Medical's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Imagin Medical Shares Outstanding | 10.83 M |
Most of Imagin Medical's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Imagin Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Imagin Medical has 10.83 M of shares currently outstending. This is 94.0% lower than that of the Healthcare sector and 93.81% lower than that of the Medical Devices industry. The shares outstanding for all United States stocks is 98.11% higher than that of the company.
Imagin Medical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Imagin Medical's current stock value. Our valuation model uses many indicators to compare Imagin Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Imagin Medical competition to find correlations between indicators driving Imagin Medical's intrinsic value. More Info.Imagin Medical is rated fourth overall in return on asset category among its peers. It is rated fifth overall in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Imagin Medical's earnings, one of the primary drivers of an investment's value.Imagin Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Imagin Medical's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Imagin Medical could also be used in its relative valuation, which is a method of valuing Imagin Medical by comparing valuation metrics of similar companies.Imagin Medical is currently under evaluation in shares outstanding category among its peers.
Imagin Fundamentals
| Return On Asset | -2.37 | |||
| Current Valuation | 7.9 M | |||
| Shares Outstanding | 10.83 M | |||
| Shares Owned By Insiders | 12.46 % | |||
| Price To Earning | (3.47) X | |||
| Price To Book | 9.05 X | |||
| EBITDA | (2.44 M) | |||
| Net Income | (2.49 M) | |||
| Cash And Equivalents | 145.67 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 8.95 M | |||
| Debt To Equity | 2.10 % | |||
| Current Ratio | 0.04 X | |||
| Book Value Per Share | (1.23) X | |||
| Cash Flow From Operations | (2.63 M) | |||
| Earnings Per Share | (0.90) X | |||
| Number Of Employees | 15 | |||
| Beta | 1.5 | |||
| Market Capitalization | 1.84 M | |||
| Total Asset | 1.35 M | |||
| Z Score | -3.3 | |||
| Net Asset | 1.35 M |
About Imagin Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Imagin Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Imagin Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Imagin Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Imagin Medical Inc. operates as a surgical imaging company focusing on bladder cancer. Imagin Medical Inc. was founded in 1986 and is headquartered in Vancouver, Canada. Imagin Medical operates under Medical Devices classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in Imagin Pink Sheet
Imagin Medical financial ratios help investors to determine whether Imagin Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Imagin with respect to the benefits of owning Imagin Medical security.